SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“Landa could become the largest printing company in the world”: Court gives troubled firm a lifeline

How artificial intelligence is reprogramming the future of games

Mapping Israel’s cybersecurity ecosystem: Funding doubles despite global headwinds

Full list of Israeli high-tech funding rounds in 2025

Buzz

Most popular

Daily

Weekly

1

Remote work’s dark side: The Soham Parekh story

2

Inside Intel's painful cuts: Who's being let go and why

3

Intel offloads $900 million in Mobileye shares to ease cash crunch

4

Intel offers up to 19 salaries to laid-off employees if they don’t fight firings

5

Intel CEO: "The strength, resilience and resolve of Intel Israel's team has no bounds"

Epitomee

4 stories about Epitomee

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki

The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway

Weight-Loss Pill Developer Epitomee Raises $8 Million

Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full